BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8896045)

  • 1. Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin-induced diabetes mellitus rats.
    Park JM; Moon CH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):343-52. PubMed ID: 8896045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats.
    Park JM; Moon CH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):353-62. PubMed ID: 8896046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):165-78. PubMed ID: 8556271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats.
    Choi YJ; Lee HJ; Kwon JW; Kim WB; Yang J; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Nov; 94(2):181-92. PubMed ID: 8987115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of streptozotocin-induced diabetes mellitus on the pharmacokinetics of nelfinavir in rats.
    Sugioka N; Sato K; Haraya K; Maeda Y; Yasuda K; Fukushima K; Ito Y; Takada K
    Biopharm Drug Dispos; 2008 Nov; 29(8):469-79. PubMed ID: 19009515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.
    Choi YH; Lee AK; Bae SK; Kim SO; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):93-8. PubMed ID: 15674819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a new proton-pump inhibitor, YJA-20379-8, after intravenous and oral administration to rats with streptozotocin-induced diabetes mellitus.
    Chung SY; Han KS; Shon SK; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Aug; 51(8):929-34. PubMed ID: 10504032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions.
    Yozai K; Shikata K; Sasaki M; Tone A; Ohga S; Usui H; Okada S; Wada J; Nagase R; Ogawa D; Shikata Y; Makino H
    J Am Soc Nephrol; 2005 Nov; 16(11):3326-38. PubMed ID: 16177002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
    Bae SK; Yang SH; Lee SJ; Kwon JW; Kim WB; Lee DC; Lee MG
    Eur J Pharm Sci; 2005 Jun; 25(2-3):337-45. PubMed ID: 15911231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
    Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
    Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
    Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced systemic availability of methotrexate in the presence of morin in rats.
    Hong SS; Jin MJ; Han HK
    Biopharm Drug Dispos; 2008 May; 29(4):189-93. PubMed ID: 18240155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the role of insulin and insulin receptor in allergic airway inflammation of rats].
    Ma YL; He QY
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3419-24. PubMed ID: 16409864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.
    Lee YS; Choi YH; Kim TK; Ryu KH; Lee BY; Lee MG
    Xenobiotica; 2010 Feb; 40(2):129-37. PubMed ID: 19929308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
    Lee HJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
    Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
    Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats.
    Fuksa L; Brcakova E; Cermanova J; Hroch M; Chladek J; Kolouchova G; Malakova J; Martinkova J; Staud F; Micuda S
    Biopharm Drug Dispos; 2008 Jul; 29(5):289-99. PubMed ID: 18548509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
    Bae SK; Lee SJ; Lee JY; Lee Y; Lee I; Kim SG; Lee MG
    Int J Pharm; 2004 May; 275(1-2):227-38. PubMed ID: 15081153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.